Ambroxol	NN	Ambroxol O TermTag
hydrochloride	NN	hydrochloride O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
management	NN	management O TermTag
of	IN	of O TermTag
idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
:	:	: : NUPOS
Clinical	JJ	clinical O TermTag
trials	NNS	trial O TermTag
are	VBP	be O TermTag
the	DT	the O TermTag
need	NN	need O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
hour	NN	hour O TermTag
.	.	. . NUPOS

Idiopathic	JJ	idiopathic O TermTag
pulmonary	JJ	pulmonary O TermTag
fibrosis	NN	fibrosis O TermTag
(	(	( ( NUPOS
IPF	NN	IPF O TermTag
)	)	) ) NUPOS
is	VBZ	be O TermTag
a	DT	a dt NUPOS
debilitating	JJ	debilitating O TermTag
lung	NN	lung O TermTag
disease	NN	disease O TermTag
of	IN	of O TermTag
unknown	JJ	unknown O TermTag
etiology	NN	etiology O TermTag
.	.	. . NUPOS

Its	PRP$	its O TermTag
pathogenesis	NN	pathogenesis O TermTag
remains	VBZ	remain O TermTag
poorly	RB	poor O TermTag
elucidated	VBN	elucidate O TermTag
but	CC	but O TermTag
aberrant	JJ	aberrant O TermTag
wound	NN	wound O TermTag
healing	NN	healing O TermTag
is	VBZ	be O TermTag
central	JJ	central O TermTag
to	TO	to O TermTag
its	PRP$	its O TermTag
pathology	NN	pathology O TermTag
.	.	. . NUPOS

It	PRP	it O TermTag
has	VBZ	have O TermTag
a	DT	a dt NUPOS
median	JJ	median O TermTag
survival	NN	survival O TermTag
time	NN	time O TermTag
of	IN	of O TermTag
3	CD	3 crd NUPOS
to	TO	to O TermTag
5	CD	5 crd NUPOS
years	NNS	year O TermTag
.	.	. . NUPOS

None	NN	none O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
treatment	NN	treatment O TermTag
modality	NN	modality O TermTag
or	CC	or O TermTag
drugs	NNS	drug O TermTag
tried	VBD	try O TermTag
in	IN	in O TermTag
its	PRP$	its O TermTag
management	NN	management O TermTag
has	VBZ	have O TermTag
so	RB	so O TermTag
far	RB	far O TermTag
changed	VBD	change O TermTag
the	DT	the O TermTag
overall	JJ	overall O TermTag
outcome	NN	outcome O TermTag
.	.	. . NUPOS

Recent	JJ	recent O TermTag
in	FW	in O TermTag
vitro	FW	vitro O TermTag
and	CC	and O TermTag
experimental	JJ	experimental O TermTag
studies	NNS	study O TermTag
have	VBP	have O TermTag
shown	VBN	show O TermTag
that	IN	that O TermTag
ambroxol	NN	ambroxol O TermTag
hydrochloride	NN	hydrochloride O TermTag
exerts	VBZ	exert O TermTag
several	JJ	several O TermTag
newer	JJR	new O TermTag
actions	NNS	action O TermTag
,	,	, , NUPOS
namely	RB	namely O TermTag
the	DT	the O TermTag
surfactant	JJ	surfactant O TermTag
stimulatory	JJ	stimulatory O TermTag
,	,	, , NUPOS
anti-imflammatory	JJ	anti-imflammatory O TermTag
and	CC	and O TermTag
anti-oxidant	JJ	anti-oxidant O TermTag
actions	NNS	action O TermTag
,	,	, , NUPOS
in	IN	in O TermTag
addition	NN	addition O TermTag
to	TO	to O TermTag
its	PRP$	its O TermTag
being	VBG	be O TermTag
a	DT	a dt NUPOS
secrrtolytic	JJ	secrrtolytic O TermTag
and	CC	and O TermTag
mucokinetic	JJ	mucokinetic O TermTag
agent	NN	agent O TermTag
.	.	. . NUPOS

The	DT	the O TermTag
anti	JJ	anti O TermTag
inflammatory	JJ	inflammatory O TermTag
and	CC	and O TermTag
anti-fibrotic	JJ	anti-fibrotic O TermTag
properties	NNS	property O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
drug	NN	drug O TermTag
are	VBP	be O TermTag
due	JJ	due O TermTag
to	TO	to O TermTag
its	PRP$	its O TermTag
ability	NN	ability O TermTag
to	TO	to O TermTag
block	VB	block O TermTag
the	DT	the O TermTag
release	NN	release O TermTag
of	IN	of O TermTag
oxidant	JJ	oxidant O TermTag
stress	NN	stress O TermTag
markers	NNS	marker O TermTag
,	,	, , NUPOS
cytokines	NNS	cytokine O TermTag
,	,	, , NUPOS
leukotrienes	NNS	leukotriene O TermTag
,	,	, , NUPOS
MPO	NN	MPO O TermTag
activity	NN	activity O TermTag
,	,	, , NUPOS
hydroxyproline	NN	hydroxyproline O TermTag
content	NN	content O TermTag
,	,	, , NUPOS
nitic	JJ	nitic O TermTag
oxide	NN	oxide O TermTag
and/or	CC	and/or O TermTag
collagen	NN	collagen O TermTag
I	PRP	i pns11 NUPOS
III	CD	III O TermTag
mRNA	NN	mRNA O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
local	JJ	local O TermTag
milieu	NN	milieu O TermTag
while	IN	while O TermTag
preserving	VBG	preserve O TermTag
the	DT	the O TermTag
SOD	NN	sod O TermTag
and	CC	and O TermTag
GSH-PX	NN	GSH-PX O TermTag
activities	NNS	activity O TermTag
.	.	. . NUPOS

In	IN	in O TermTag
human	JJ	human O TermTag
studies	NNS	study O TermTag
also	RB	also O TermTag
,	,	, , NUPOS
the	DT	the O TermTag
agent	NN	agent O TermTag
was	VBD	be O TermTag
able	JJ	able O TermTag
to	TO	to O TermTag
block	VB	block O TermTag
the	DT	the O TermTag
expression	NN	expression O TermTag
of	IN	of O TermTag
TGF-beta	NN	TGF-beta GENE TermTag
and	CC	and O TermTag
TNF-alpha	NN	TNF-alpha GENE TermTag
in	IN	in O TermTag
plasma	NN	plasma O TermTag
and	CC	and O TermTag
preserving	VBG	preserve O TermTag
the	DT	the O TermTag
carbon	NN	carbon O TermTag
monoxide	NN	monoxide O TermTag
diffusion	NN	diffusion O TermTag
capacity	NN	capacity O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
lungs	NNS	lung O TermTag
in	IN	in O TermTag
lung	NN	lung O TermTag
cancer	NN	cancer O TermTag
patients	NNS	patient O TermTag
on	IN	on O TermTag
radiation	NN	radiation O TermTag
therapy	NN	therapy O TermTag
.	.	. . NUPOS

Thus	RB	thus O TermTag
,	,	, , NUPOS
ambroxol	NN	ambroxol O TermTag
may	MD	may O TermTag
have	VB	have O TermTag
the	DT	the O TermTag
potential	JJ	potential O TermTag
to	TO	to O TermTag
check	VB	check O TermTag
the	DT	the O TermTag
dysregulated	VBN	dysregulate O TermTag
healing	NN	healing O TermTag
process	NN	process O TermTag
that	WDT	that O TermTag
is	VBZ	be O TermTag
typical	JJ	typical O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

This	DT	this O TermTag
,	,	, , NUPOS
coupled	VBN	couple O TermTag
with	IN	with O TermTag
its	PRP$	its O TermTag
safety	NN	safety O TermTag
profile	NN	profile O TermTag
for	IN	for O TermTag
human	JJ	human O TermTag
use	NN	use O TermTag
,	,	, , NUPOS
warrants	NNS	warrant O TermTag
clinical	JJ	clinical O TermTag
trials	NNS	trial O TermTag
of	IN	of O TermTag
the	DT	the O TermTag
drug	NN	drug O TermTag
in	IN	in O TermTag
the	DT	the O TermTag
management	NN	management O TermTag
of	IN	of O TermTag
IPF	NN	IPF O TermTag
.	.	. . NUPOS

